chr9-676973-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate

The NM_001354333.2(KANK1):​c.-507A>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00000411 in 1,461,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

KANK1
NM_001354333.2 5_prime_UTR_premature_start_codon_gain

Scores

5
5
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.40

Publications

0 publications found
Variant links:
Genes affected
KANK1 (HGNC:19309): (KN motif and ankyrin repeat domains 1) The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
KANK1 Gene-Disease associations (from GenCC):
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 2
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.849

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001354333.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
NM_015158.5
MANE Select
c.1A>Tp.Met1?
initiator_codon
Exon 2 of 12NP_055973.2Q14678-1
KANK1
NM_001354333.2
c.-507A>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 12NP_001341262.1Q14678-2
KANK1
NM_001256876.3
c.1A>Tp.Met1?
initiator_codon
Exon 6 of 16NP_001243805.1Q14678-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
ENST00000382297.7
TSL:1 MANE Select
c.1A>Tp.Met1?
initiator_codon
Exon 2 of 12ENSP00000371734.2Q14678-1
KANK1
ENST00000382303.5
TSL:1
c.1A>Tp.Met1?
initiator_codon
Exon 6 of 16ENSP00000371740.1Q14678-1
KANK1
ENST00000382289.7
TSL:1
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 10ENSP00000371726.3Q5W0W3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251192
AF XY:
0.00000737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000411
AC:
6
AN:
1461526
Hom.:
0
Cov.:
30
AF XY:
0.00000688
AC XY:
5
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33458
American (AMR)
AF:
0.00
AC:
0
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86186
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111798
Other (OTH)
AF:
0.00
AC:
0
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.14
CADD
Uncertain
24
DANN
Benign
0.94
DEOGEN2
Benign
0.024
T
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.49
D
MetaRNN
Pathogenic
0.85
D
MetaSVM
Benign
-0.78
T
PhyloP100
5.4
PROVEAN
Benign
-1.4
N
REVEL
Uncertain
0.38
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.17
T
Polyphen
0.70
P
Vest4
0.89
MutPred
0.57
Loss of methylation at K6 (P = 0.0779)
MVP
0.18
ClinPred
0.98
D
GERP RS
5.6
PromoterAI
0.020
Neutral
Varity_R
0.89
gMVP
0.19
Mutation Taster
=15/185
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1485932719; hg19: chr9-676973; API